ALB and neoplasm: Based on the ex vivo biodistribution studies, the integration of the albumin-binding unit led to the enhancement of the tumor uptake and the decrease in renal accumulation of the IPB containing radiotracer, while the circulation time of the modified radiopharmaceutical increased significantly.